Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Link

Showing results (651-660 of 673) with videos related to

Pageof 68
Sort By:
Medizinische Klinik (Munich, Germany : 1983)|April 12, 1996
[Intensive post-remission therapy in acute myeloid leukemia. Results of a prospective comparative study by the South Germany Hemoblastosis Group]G Hübner, H Link, P Schönrock-Nabulsi, et al.
Medizinische Klinik (Munich, Germany : 1983)|April 12, 1996
[Therapy of chronic myeloid leukemia with interferon-alpha. A decade of experiences]M Freund, P Heussner, F Hild, et al.
Haematology and Blood Transfusion|January 1, 1983
Bone marrow transplantation in West Germany in patients with leukemiaK Wilms, K Schüch, C Müller, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|September 18, 2009
[Quality criteria for treatment of colorectal cancer. From a surgeon's viewpoint]K H Link, M Kornmann, R Bittner, et al.
British Journal of Cancer|December 11, 2008
Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trialG Huebner, H Link, C H Kohne, et al.
Annals of Hematology|September 1, 2017
Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)W J Heinz, D Buchheidt, M Christopeit, et al.
Annals of Hematology|October 6, 1998
Outcome of peripheral blood stem cell mobilization in advanced phases of CML is dependent on the type of chemotherapy appliedT Fischer, A Neubauer, J Mohm, et al.
Blood|June 20, 1998
Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemiaH Wandt, M Frank, G Ehninger, et al.
Leukemia|March 17, 2006
Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline- based chemotherapy: the European APL group experience (APL 91 and APL 93 trials)C Kelaidi, L Ades, S Chevret, et al.
Leukemia|August 15, 2000
Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL groupP Fenaux, S Chevret, A Guerci, et al.
Pageof 68

Showing results (651-660 of 673) with videos related to

Sort By:
Pageof 68
Medizinische Klinik (Munich, Germany : 1983)|April 12, 1996
[Intensive post-remission therapy in acute myeloid leukemia. Results of a prospective comparative study by the South Germany Hemoblastosis Group]G Hübner, H Link, P Schönrock-Nabulsi, et al.
Medizinische Klinik (Munich, Germany : 1983)|April 12, 1996
[Therapy of chronic myeloid leukemia with interferon-alpha. A decade of experiences]M Freund, P Heussner, F Hild, et al.
Haematology and Blood Transfusion|January 1, 1983
Bone marrow transplantation in West Germany in patients with leukemiaK Wilms, K Schüch, C Müller, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|September 18, 2009
[Quality criteria for treatment of colorectal cancer. From a surgeon's viewpoint]K H Link, M Kornmann, R Bittner, et al.
British Journal of Cancer|December 11, 2008
Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trialG Huebner, H Link, C H Kohne, et al.
Annals of Hematology|September 1, 2017
Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)W J Heinz, D Buchheidt, M Christopeit, et al.
Annals of Hematology|October 6, 1998
Outcome of peripheral blood stem cell mobilization in advanced phases of CML is dependent on the type of chemotherapy appliedT Fischer, A Neubauer, J Mohm, et al.
Blood|June 20, 1998
Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemiaH Wandt, M Frank, G Ehninger, et al.
Leukemia|March 17, 2006
Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline- based chemotherapy: the European APL group experience (APL 91 and APL 93 trials)C Kelaidi, L Ades, S Chevret, et al.
Leukemia|August 15, 2000
Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL groupP Fenaux, S Chevret, A Guerci, et al.
Pageof 68